Louise Newson - Menopause and Cardiovascular Disease | INTERVIEWS WITH MARLA SHAPIRO

10 Views
Published
The International Menopause Society is proud to provide the interview series for health care professionals on current topics of interest in the field of menopause.
In the series, IMS Board Member Dr. Marla Shapiro interviews renowned experts on menopause and midlife women’s health.

In this episode Prof. Louise Newson will talk about “Menopause and cardiovascular disease”.
Cardiovascular disease is one of the leading causes of death in women. Women who start HRT within 10 years of the menopause have a reduction of coronary heart disease. Transdermal oestradiol is a vasodilator as well as having specific beneficial effects on endothelial cells including improving production of beneficial nitric oxide and prostacyclin as well as reducing production of endothelin and angiotensin II which are vasoconstrictors. HRT is actually more beneficial to women than taking a statin or blood pressure lowering drug for the primary prevention of cardiovascular disease.

The interview is available as podcast:

The views expressed by speakers are their own and may not necessarily represent the views of the IMS
Category
Hormones
Be the first to comment